Crizalk also known as Crizotininb & Xalokori in other parts of the world is a prescription medicine manufactured by Pfizer used to treat non-small cell lung cancer (NSCLC) that is advanced or has spread to other parts of the body and is caused by a defect in a gene called ALK (anaplastic lymphoma kinase). XALKORI approval is based on the percentage of patients whose tumors responded to treatment. It is manufactured by Pfizer. Available in 250 mg dosage. 60 tablet pack. It is approved by the US FDA. It is sold by the name of Crizalk in India, and cheaper than Xalkori.
Pay Mode Terms: L/C (Letter of Credit), T/T (Bank Transfer)
F. O. B. Price Order: 1500 USD
Minimum Order Quantity: 10 Pack
Port of Dispatch: Mumbai
Production Capacity: 200
Delivery Time: 5-10 days